Global Genotyping Market to Reach US$ 57.4 Billion by 2032, Propelled by Increasing Demand for Genotypic-based Diagnostics

August 23, 2022 | Healthcare

According to the latest report by IMARC Group, titled "Genotyping Market Report by Product and Service (Instruments, Reagents and Kits, Software and Services), Technology (Polymerase Chain Reaction (PCR), Capillary Electrophoresis, Microarray, Sequencing, Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, and Others), and Region 2024-2032," the global genotyping market reached a value of US$ 19.4 Billion in 2023. Genotyping is a laboratory-based analytical approach that analyzes deoxyribonucleic acid (DNA) sequences to determine the genetic composition in genotypes of various living organisms, such as plants, animals, and microorganisms. It uses a set of biological tests that assists in comparing a single sample with the other sequences and noting the differences between individuals by using genetic history data of an individual, determining the fatherhood and motherhood, and preventing the spread of pathogens by tracking the origin of the outbreak. Genetic evaluations allow examiners to assess genetic make-up and several deviations, including significant structural changes in DNA and single nucleotide polymorphisms, by identifying genetic differences through biological assays. Apart from this, genotyping offers high efficiency, operational flexibility, and access to multiple parameters in single testing; thus, it finds extensive applications in agricultural biotechnology, diagnostics, and research institutes.

Global Genotyping Market Trends:

The increasing demand for genotypic-based diagnostic testing and bioinformatics solutions in data analysis and the increasing prevalence of various genetic disorders are primarily driving the market growth. The adoption of genotyping in the healthcare industry helps practitioners make point-of-care decisions and develop personalized medicines by analyzing multiple markers and probes, detecting sample outliers, and identifying relevant genetic variations for implementation. In line with this, the extensive utilization of genotyping in pharmacogenomics, animal genetics, food hygiene determination, and atmospheric testing in distant places or industrial settings, forensics, and drug development to provide information for the practice of personalized medicine regarding the proper medication and dosage is acting as another growth-inducing factor. Additionally, the rising health concerns and the sudden outbreak of the COVID-19 pandemic across the globe prompted pharmaceutical companies to introduce genotyping kits to detect SARS-CoV-2 variants, which is contributing to the market growth. Moreover, the advent of technologies that offer superior accuracy in disease diagnosis and the uptake of single nucleotide polymorphisms (SNP) genotyping for formulating effective medications are positively stimulating the market growth. Furthermore, significant improvements in the healthcare infrastructure have augmented the need for reagents in genotyping tests, which is impelling the market growth. Other factors, such as the escalating consumer awareness regarding the availability of personalized medicines and ongoing research and development (R&D) activities in the precision medicine research field, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 57.4 Billion by 2032, growing at a CAGR of 12.5% during 2024-2032.

Market Summary:

  • Based on the product and service, the market has been classified into instruments, reagents and kits, and software and services.
  • On the basis of technology, the market has been segregated into polymerase chain reaction (PCR), capillary electrophoresis, microarray, sequencing, mass spectrometry, and others.
  • Based on the application, the market has been segmented into pharmacogenomics, diagnostics and personalized medicine, agricultural biotechnology, animal genetics, and others.
  • On the basis of the end user, the market has been categorized into pharmaceutical and biopharmaceutical companies, diagnostics and research laboratories, academic institutes, and others.
  • On a regional basis, the market has been segmented into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa.
  • The competitive landscape of the industry has also been examined, with some of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Qiagen N.V, Standard BioTools Inc. and Thermo Fisher Scientific Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product and Service, Technology, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Qiagen N.V, Standard BioTools Inc. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Genotyping Market to Reach US$ 57.4 Billion by 2032, Propelled by Increasing Demand for Genotypic-based Diagnostics
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More